Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?
Serdar SahinÖzlem HaliloğluOzge Polat KorkmazEmre DurcanHümeyra Rekalı ŞahinVolkan Demirhan YumukTaner DamcıHasan Mahmut İlkovaZeynep Oşar SivaPublished in: Turkish journal of medical sciences (2020)
The QoL was improved in people with diabetes who were taking SGLT2 inhibitors. This may be explained by weight loss observed in participants.